Skip to content
Zorev

Demonstration

See a thesis built, challenged and monitored.

Zorev moves from company disclosures to structured claims, supporting and conflicting evidence, scenarios, a counter-thesis and continuous monitoring. The analysis below uses an illustrative company.

Illustrative company — not a real issuer

An illustrative analysis, end to end.

Every figure, claim and conclusion below is fictional and shown solely to demonstrate the methodology.

Illustrative company — not a real issuerIllustrative data

Northvale Industrials

A fictional industrial-components manufacturer used solely to demonstrate the methodology. Northvale Industrials is not a real issuer and does not use this platform.

Initial investment question
Is the recent margin improvement structural enough to support a higher valuation?
Business and financial drivers
Aftermarket mix, pricing actions, input costs, inventory days, capital expenditure and cost of capital.

Aftermarket revenue is structurally growing.

Supporting evidence
Segment disclosure shows five consecutive years of aftermarket growth above group average.
Conflicting evidence
Two of those years benefited from an acquisition disclosed in the FY2022 report.
Confidence level
Moderate

Margin improvement is sustainable.

Supporting evidence
Gross margin recovered 120 bps, described by management as an efficiency programme outcome.
Conflicting evidence
Input-cost relief accounts for a significant part of the improvement.
Confidence level
Low — reduced after review

Cash conversion normalises as working capital unwinds.

Supporting evidence
Inventory days elevated versus the five-year average following a supply build.
Conflicting evidence
FCF conversion has declined for three consecutive periods.
Confidence level
Moderate

Scenario assumptions and valuation implications

Each case is linked to explicit assumptions for growth, pricing, margins, working capital, capital expenditure and cost of capital. Illustrative value per share.

Upside — full margin recovery61
Base — partial recovery51
Downside — no recovery42

Counter-thesis

Challenging a positive conclusion

  1. Initial conclusion

    Margin improvement appears sustainable.

  2. Contradictory evidence

    A significant part of the improvement resulted from temporary input-cost relief rather than structural operating efficiency.

  3. ZOREV ASSESSMENT

    Thesis confidence reduced until the company demonstrates sustained productivity gains.

Risks

  • Demand softening in the principal end-market
  • Input costs reverting to prior levels
  • Working capital remaining elevated
  • Leverage rising towards covenant capacity

Catalysts

  • Evidence of sustained productivity gains
  • Working-capital release converting into free cash flow
  • Aftermarket growth continuing without acquisition support

Invalidation conditions

  • Operating margin fails to improve over two further reporting periods
  • FCF conversion remains below 65 per cent
  • Net debt / EBITDA exceeds 2.5x without a stated deleveraging path

A new disclosure changes the thesis

Monitoring event — illustrative

  1. New evidence

    Q3 interim report discloses that hedged input costs roll off in the next financial year.

  2. Assumption affected

    Base-case margin recovery of +120 bps.

  3. Effect on the thesis

    Weakened — the base case now depends on productivity gains not yet evidenced.

  4. What to investigate next

    Segment-level cost disclosure and management commentary on the efficiency programme.

What the demonstration covers

Five parts of the analytical process.

  1. 01

    Evidence collection and structuring

    See how relevant information is identified and connected to its source and publication date.

  2. 02

    Thesis construction

    Explore how claims, assumptions and value drivers are made explicit.

  3. 03

    Counter-thesis

    See how the platform questions assumptions and surfaces contradictory evidence.

  4. 04

    Connected scenarios and valuation

    Understand how changes in assumptions affect financial outcomes and valuation.

  5. 05

    Continuous monitoring

    See how a new disclosure is compared with the existing thesis and its assumptions.

Request a demonstration

Fields marked with an asterisk are required.

Information submitted through this form is handled as described in our privacy statement.

FAQ

Frequently asked questions.